Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...

"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...

In a little over two decades, almost 260 million people in the United States are predicted to be overweight or obese, ...